Allogene Therapeutics Inc (ALLO)

Aug 19, 2025

Allogene Q2 Cash Tops $300 Million - AOL.com

Aug 19, 2025

Aug 19, 2025

Allogene Therapeutics Inc. Facing Inflection Point in Trend AnalysisPrice Action & Daily Entry Point Alerts - beatles.ru

Aug 19, 2025

Aug 19, 2025

Real time pattern detection on Allogene Therapeutics Inc. stockJuly 2025 Short Interest & Low Risk Growth Stock Ideas - Newser

Aug 19, 2025

Aug 19, 2025

Ranking Allogene Therapeutics Inc. among high performing stocks via toolsTrade Volume Summary & Weekly Top Gainers Alerts - Newser

Aug 19, 2025

Aug 19, 2025

Will Allogene Therapeutics Inc. outperform the marketJuly 2025 Spike Watch & Reliable Price Action Trade Plans - Newser

Aug 19, 2025

Aug 19, 2025

Full technical analysis of Allogene Therapeutics Inc. stockWeekly Gains Summary & Safe Capital Allocation Plans - Newser

Aug 19, 2025

Aug 19, 2025

How to track smart money flows in Allogene Therapeutics Inc.Portfolio Profit Report & Community Supported Trade Ideas - Newser

Aug 19, 2025

Aug 19, 2025

What machine learning models say about Allogene Therapeutics Inc.2025 EndofYear Setup & Growth Focused Stock Pick Reports - Newser

Aug 19, 2025

Aug 19, 2025

Backtesting results for Allogene Therapeutics Inc. trading strategiesBreakout Watch & Advanced Swing Trade Entry Plans - Newser

Aug 19, 2025

Aug 19, 2025

What recovery options are there for Allogene Therapeutics Inc.Weekly Market Summary & Safe Capital Allocation Plans - Newser

Aug 19, 2025

Aug 19, 2025

Published on: 2025-08-19 03:10:25 - Newser

Aug 19, 2025

Aug 18, 2025

Allogene's Q2 Loss Narrower Than Expected, Pipeline in Focus - MSN

Aug 18, 2025

Aug 18, 2025

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q2 2025 Earnings Call Transcript - MSN

Aug 18, 2025

Aug 18, 2025

Can swing trading help recover from Allogene Therapeutics Inc. losses2025 Macro Impact & Low Risk Entry Point Tips - Newser

Aug 18, 2025

Aug 18, 2025

Signal strength of Allogene Therapeutics Inc. stock in tech scannersJuly 2025 Chart Watch & Safe Entry Point Identification - Newser

Aug 18, 2025

Aug 17, 2025

Will Allogene Therapeutics Inc. benefit from macro trendsJuly 2025 Levels & Weekly High Momentum Picks - Newser

Aug 17, 2025

Aug 17, 2025

Allogene Therapeutics Inc. stock chart pattern explainedBuy Signal & Breakout Confirmation Trade Signals - Newser

Aug 17, 2025

Aug 16, 2025

Understanding Allogene Therapeutics Inc.’s price movementTrade Analysis Report & Verified Swing Trading Watchlist - Newser

Aug 16, 2025

Aug 15, 2025

Allogene Therapeutics Faces Financial Uncertainty Amid New U.S. Tariffs and Regulatory Challenges - TipRanks

Aug 15, 2025

Aug 15, 2025

Allogene Therapeutics Q2 2025 Earnings Preview: Revenue Expectations Flat, Earnings Estimates Rise - AInvest

Aug 15, 2025

Aug 14, 2025

Allogene Therapeutics: Important Catalysts Guided For Early 2026 (NASDAQ:ALLO) - Seeking Alpha

Aug 14, 2025

Aug 14, 2025

Crispr Therapeutics shares rise 3.12% intraday after Allogene Therapeutics' positive trial updates. - AInvest

Aug 14, 2025

Aug 14, 2025

TD Cowen Maintains Allogene Therapeutics(ALLO.US) With Buy Rating - 富途牛牛

Aug 14, 2025

Aug 14, 2025

Allogene's Q2 Loss Narrower Than Expected, Pipeline In Focus - Barchart.com

Aug 14, 2025

Aug 14, 2025

Allogene Therapeutics shares rise 1.92% premarket after reporting better-than-expected Q2 earnings. - AInvest

Aug 14, 2025

Aug 14, 2025

Allogene outlines clinical milestones with MRD data readout planned for first half 2026 as portfolio advances - MSN

Aug 14, 2025

Aug 14, 2025

Allogene Therapeutics’ SWOT analysis: stock faces challenges amid promising pipeline - Investing.com

Aug 14, 2025

Aug 14, 2025

Allogene Therapeutics’ SWOT analysis: stock faces challenges amid promising pipeline By Investing.com - Investing.com South Africa

Aug 14, 2025

Aug 14, 2025

Allogene Therapeutics: Q2 Earnings Snapshot - Greenwich Time

Aug 14, 2025

Aug 14, 2025

Allogene Therapeutics Inc (ALLO) Q2 2025 Earnings Call Highlights: Strategic Advancements Amid ... - Yahoo Finance

Aug 14, 2025

Aug 14, 2025

Oppenheimer Maintains Allogene Therapeutics(ALLO.US) With Buy Rating, Maintains Target Price $7 - 富途牛牛

Aug 14, 2025

Aug 13, 2025

Allogene Therapeutics Advances in CAR T Cell Therapy - TipRanks

Aug 13, 2025

Aug 13, 2025

ALPHA3 Trial Update: Contradictions in Enrollment, Data Expectations, and Lymphodepletion Strategies - AInvest

Aug 13, 2025

Aug 13, 2025

Allogene Therapeutics Q2 2025 Earnings: A Strategic Leap in Cell Therapy Commercialization - AInvest

Aug 13, 2025

Aug 13, 2025

Transcript : Allogene Therapeutics, Inc., Q2 2025 Earnings Call, Aug 13, 2025 - MarketScreener

Aug 13, 2025

Aug 13, 2025

Allogene's Strategic Milestone Progress in 2026 and Its Implications for CAR T Leadership - AInvest

Aug 13, 2025

Aug 13, 2025

Earnings call transcript: Allogene Therapeutics’ Q2 2025 earnings reveal strategic shifts - Investing.com Nigeria

Aug 13, 2025

Aug 13, 2025

Allogene Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 13, 2025

Aug 13, 2025

Allogene Narrows Loss in Fiscal Q2 - Nasdaq

Aug 13, 2025

Aug 13, 2025

Allogene Therapeutics, Inc. SEC 10-Q Report - TradingView

Aug 13, 2025

Aug 13, 2025

Allogene Therapeutics Advances Pivotal Phase 2 ALPHA3 Trial for Cema-Cel in Large B-Cell Lymphoma and Initiates Phase 1 Trials for Autoimmune Disease and Renal Cell Carcinoma - Quiver Quantitative

Aug 13, 2025

Aug 13, 2025

Allogene Therapeutics Reports Second Quarter 2025 Financial Results and Business Update - The Manila Times

Aug 13, 2025

Aug 13, 2025

Allogene's CAR T Trials Show Promise in Cancer and Autoimmune Disease, $302M Cash Position - Stock Titan

Aug 13, 2025

Aug 12, 2025

Allogene Therapeutics Q2 2025 Earnings Call Transcript - MarketBeat

Aug 12, 2025

Aug 12, 2025

Allogene Therapeutics Inc (ALLO) Q2 2025 Earnings Report Preview: What To Expect - Yahoo Finance

Aug 12, 2025

Aug 11, 2025

Allogene Therapeutics Inc expected to post a loss of 27 cents a shareEarnings Preview - TradingView

Aug 11, 2025

Aug 09, 2025

Allogene Therapeutics Inc. stock trend forecastMarket Stability and Long-Term Growth Outlook - Newser

Aug 09, 2025